---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-005242"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2022-02-23T23:59:59+00:00"
generated_at: "2026-06-27T05:18:43.262690+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nephros FY2021 revenue $10.4M (+22% YoY); net loss narrows to $3.9M

## Summary
- Full-year revenue $10.4M, up 22% from $8.6M in 2020; Q4 revenue $2.8M, up 18%.
- Full-year net loss ($3.9M) improved 15% from ($4.5M); Adjusted EBITDA ($2.6M) improved 29%.
- Q4 water filtration segment revenue $2.7M (+16%); operating loss ($0.7M).
- Reaffirms FY2022 revenue guidance of $13.0-13.5M, representing 25-30% growth.
- Cash and cash equivalents $7.0M as of Dec 31, 2021.

## SEC filing metadata
- accession: 0001493152-22-005242
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2022-02-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315222005242/0001493152-22-005242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315222005242/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-005242
- JSON: https://secwatch.observer/filing/0001493152-22-005242.json
- Plain text: https://secwatch.observer/filing/0001493152-22-005242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.